Article
Pioglitazone rescues high-fat diet-induced depression-like phenotypes and hippocampal astrocytic deficits in mice.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Aug 2021
Lam Ying-Yiu, Tsai Sheng-Feng, Chen Pei-Chun, Kuo Yu-Min, Chen Yun-Wen
Abstract excerpt
The prevalence of diabetes is rapidly increasing worldwide and is highly associated with the incidence of depression. Pioglitazone, a Peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, is widely used for treating patients with type 2 diabetes. However, whether pioglitazone alleviates metabolic disorder-related depression and astrocytic deficits remains unclear. Here we showed that 12 weeks of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
